A. O’Neill
Impact in
Papers in
- Oncology 9
- Cancer Immunotherapy and Biomarkers 3
- HER2/EGFR in Cancer Research 2
- Peptidase Inhibition and Analysis 2
- Cancer-related Molecular Pathways 2
-
- Thyroid Cancer Diagnosis and Treatment 3
- Co-authors
- Stuart A. Grossman (2 shared papers)Kathryn A. Carson (2 shared papers)Tracy T. Batchelor (2 shared papers)Jane B. Alavi (1 shared paper)Fred H. Hochberg (1 shared paper)Pamela New (1 shared paper)Daniel F.C. Hayes (1 shared paper)Rebecca Sue Gelman (1 shared paper)
- Journals
- Journal of Clinical Oncology (4 papers)Annals of Oncology (3 papers)British Journal of Cancer (2 papers)European Journal of Obstetrics & Gynecology and Reproductive Biology (1 paper)Sarcoma (1 paper)
- Partner nations
- United StatesIrelandPoland
In The Last Decade
A. O’Neill
20 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 87
- Genetics 509
- Neurology 461
- Immunology and Allergy 129
- Oncology 455
- Pathology and Forensic Medicine 304
Countries citing papers authored by A. O’Neill
This map shows the geographic impact of A. O’Neill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. O’Neill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. O’Neill more than expected).
Fields of papers citing papers by A. O’Neill
This network shows the impact of papers produced by A. O’Neill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. O’Neill. The network helps show where A. O’Neill may publish in the future.
Co-authors
The 25 scholars most cited alongside A. O’Neill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 448 | |
| 2 | 2008 | 411 | |
| 3 | 1997 | 211 | |
| 4 | 2010 | 134 | |
| 5 | 2007 | 98 | |
| 6 | 2002 | 63 | |
| 7 | 2013 | 37 | |
| 8 | 2013 | 36 | |
| 9 | 2015 | 24 | |
| 10 | 2011 | 23 | |
| 11 | 2022 | 20 | |
| 12 | 2013 | 20 | |
| 13 | 2021 | 8 | |
| 14 | 2022 | 7 | |
| 15 | 2022 | 6 | |
| 16 | Pilot trial of paclitaxel-herceptin adjuvant therapy for early stage breast cancer (E2198) | 2001 | 5 |
| 17 | DOD Renewable Energy Projects: Improved Guidance Needed for Analyzing and Documenting Costs and Benefits | 2016 | 4 |
| 18 | 2008 | 4 | |
| 19 | 2023 | 2 | |
| 20 | 2024 | 2 |
About A. O’Neill
A. O’Neill is a scholar working on Oncology, Endocrinology, Diabetes and Metabolism, Neurology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 20 papers that have together received 1.6k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), HER2/EGFR in Cancer Research (2 papers), Peptidase Inhibition and Analysis (2 papers), Cancer-related Molecular Pathways (2 papers), Angiogenesis and VEGF in Cancer (2 papers), Sarcoma Diagnosis and Treatment (1 paper) and Neuroblastoma Research and Treatments (1 paper). The work is most often cited by research in Genetics (509 citations), Neurology (461 citations), Immunology and Allergy (129 citations), Oncology (455 citations) and Pathology and Forensic Medicine (304 citations). A. O’Neill has collaborated with scholars based in United States, Ireland and Poland. Frequent co-authors include Stuart A. Grossman, Kathryn A. Carson, Tracy T. Batchelor, Jane B. Alavi, Fred H. Hochberg, Pamela New, Daniel F.C. Hayes, Rebecca Sue Gelman, Hideko Yamauchi and Walter P. Carney. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, European Journal of Obstetrics & Gynecology and Reproductive Biology and Sarcoma.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.